Posted by linkadge on April 6, 2021, at 19:39:04
In reply to New SNRI approved for ADHD: Viloxazine, posted by PeterMartin on April 6, 2021, at 10:16:29
Interesting. Although, the 5-ht2c agonism, would counteract (to some extent) the increase in prefrontal dopamine from the NRI action.
Linkadge
poster:linkadge
thread:1114436
URL: http://www.dr-bob.org/babble/20210120/msgs/1114439.html